Potential phytochemicals in the prevention and treatment of esophagus cancer: A green therapeutic approach

被引:0
作者
Banzeer Ahsan Abbasi
Javed Iqbal
Riaz Ahmad
Sitara Bibi
Tariq Mahmood
Sobia Kanwal
Sheeza Bashir
Farhat Gul
Safia Hameed
机构
[1] Quaid-i-Azam University,Department of Plant Sciences
[2] Shaanxi Normal University,College of Life Sciences
[3] University of Gujrat,Department of Zoology
[4] Quaid-i-Azam University,Department of Biotechnology
来源
Pharmacological Reports | 2019年 / 71卷
关键词
Esophagus cancer; Phytochemicals; Anticancer drugs; Chemotherapy; Radiation therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Globally, esophagus cancer (EC) is one of the most frequently reported malignancies and leading cause of deaths. Currently, different treatment methods are available like chemotherapy, radiation therapy, surgery or their combination. These treatment strategies are not enough and are often associated with adverse side effects. The alternate treatment option like phytochemicals have come up with ease of bioavailability and cost-effectiveness. Due to general acceptance, lower side effects, safety and pleiotropic effect, phytochemicals can be used as an adjuvant treatment for alleviating side effects associated with chemotherapy and radiotherapy. Phytochemicals perform multiple functions; release cytochrome-c, loss mitochondrial membrane potential, down-regulate expression of anti-apoptotic proteins, up-regulate pro-apoptotic proteins, activate caspases, p53, inhibit Akt/mTOR signaling pathway, phosphorylate NF-κB, STAT3 and PI3K. The knowledge compiled here encompasses anti-EC phytochemicals, their occurrence, bioavailability therapeutic effects and mechanism of action by targeting several genes and signaling pathways. Overall, the clinical data compiled on phytochemicals against EC is not sufficient and need future research to provide additional insights for developing potential anticancer drugs in pharma industries.
引用
收藏
页码:644 / 652
页数:8
相关论文
共 554 条
  • [1] Ueda H(2017)Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer Oncotarget 8 80286-94
  • [2] Takeda M(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin 68 394-424
  • [3] Ueda S(2016)Apigenin induced apoptosis in esophageal carcinoma cells by destruction membrane structures Scanning 38 322-8
  • [4] Kawakami H(2018)Cancer Statistics, 2018 CA Cancer J Clin 68 7-30
  • [5] Okuno T(2013)Oesophageal carcinoma Lancet 381 400-12
  • [6] Takegawa N(2011)Epidemiologic risk factors for esophageal cancer development Asian Pac J Cancer Prev 12 2461-6
  • [7] Bray F(2009)Esophageal cancer in Kashmir (India): an enigma for researchers Int J Health Sci 3 71-85
  • [8] Ferlay J(2014)Study on socio-demographic and associated risk factors for oesophageal cancer in Karnataka Institute of Medical Sciences Hospital, Hubli, Karnataka J App Med Sci 2 706-10
  • [9] Soerjomataram I(2015)Global incidence of oesophageal cancer by histological subtype in 2012 Gut 64 381-7
  • [10] Siegel RL(2013)Epidemiology of esophageal cancer World J gastroenterol 19 5598-606